Innate Pharma (IPHA) Assets (2017 - 2026)
Innate Pharma (IPHA) reported Assets of $40.36 million for the quarter ended Jun 30, 2026, down 61.6% from $105.2 million a year earlier.
Powered by 
Analysis
Innate Pharma (IPHA) Assets (2017 - 2026) Analysis & Trends
As of Dec 31, 2025, Innate Pharma posted Assets of $70.86 million, down 41.0% from the prior year.
- Assets has declined for seven consecutive years, with a five-year compound annual growth rate of -27.4% (years ended Dec 2020 to Dec 2025).
- By year, Assets came in at $120.2 million in the year ended Dec 31, 2024 (-39.7%), $199.24 million in the year ended Dec 31, 2023 (-9.1%), $219.08 million in the year ended Dec 31, 2022 (-28.4%) and $306.01 million in the year ended Dec 31, 2021 (-12.8%).
- The figure for the quarter ended Jun 30, 2026 ranks as the lowest quarterly Assets in data going back to the quarter ended Dec 31, 2017.
- Across the past five years, year-over-year decline in Assets ran from 7.3% in the quarter ended Dec 31, 2023 to 61.6% in the quarter ended Jun 30, 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,128.06 Bn | 1,096.64 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 615.47 Bn | 534.00 Bn | 17.26 Bn | 201.06 Bn |
| 3 | AbbVie | 504.80 Bn | 477.91 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 368.45 Bn | 322.83 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 298.44 Bn | 262.43 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 261.92 Bn | 235.60 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 236.10 Bn | 191.50 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 190.71 Bn | 164.91 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 170.16 Bn | 116.81 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Innate Pharma | 140.66 Mn | -66.54 Mn | - | 39.66 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 39.66 Mn |
| Dec 31, 2025 | 73.68 Mn |
| Jun 30, 2025 | 108.99 Mn |
| Dec 31, 2024 | 115.57 Mn |
| Jun 30, 2024 | 162.23 Mn |
| Dec 31, 2023 | 193.90 Mn |
| Jun 30, 2023 | 216.33 Mn |
| Dec 31, 2022 | 212.46 Mn |
| Jun 30, 2022 | 292.95 Mn |
| Dec 31, 2021 | 302.94 Mn |
| Jun 30, 2021 | 316.85 Mn |
| Dec 31, 2020 | 378.13 Mn |
| Jun 30, 2020 | 374.61 Mn |
| Dec 31, 2019 | 449.62 Mn |
| Dec 31, 2018 | 516.19 Mn |
| Dec 31, 2017 | 304.54 Mn |
API Access
Innate Pharma Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=IPHA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "IPHA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=IPHA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();